Back to company

Vesper Bio ApS: Financial statements 2012

CVR: 32879861

Vesper Bio ApS (CVR 32879861) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -21,599 and a net result of DKK -16,199. Equity amounted to DKK 376,837. The solvency ratio was 99.2%.

Gross Profit
-21,599 kr.
Profit/Loss
-16,199 kr.
Equity
376,837 kr.
Total Assets
379,836 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Vesper Bio ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2012

Vesper Bio ApS appoints new auditorJan 1, 2012

As of January 1, 2012, RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Vesper Bio ApS.

Auditor steps down at Vesper Bio ApSJan 1, 2012

As of January 1, 2012, REVISIONSFIRMA SVENDSEN & SØRENSEN I/S has stepped down as auditor of Vesper Bio ApS.

About Vesper Bio ApS

Vesper Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named INSUSENSE ApS. The management consists of Jacob Falck Hansen. The company is owned by 75PMK Holding ApS and LUNDBECKFONDEN. The company has 3 employees. In 2025, the company reported a gross profit of DKK -36,446,130 and a net result of DKK -48,200,991 compared with DKK -66,506,349 the year before. Equity amounted to DKK -227,433,239.